Fructose alters adiponectin, haptoglobin and angiotensinogen gene expression in 3T3-L1 adipocytes

Nutrition Research

Volumn 30, Issue 9, 2010, Pages 644-649

  Carvalho, Carla R ^a   Bueno, Allain A ^a   Mattos, Ana M ^a   Biz, Carolina ^a   de Oliveira, Cristiane ^a   Pisani, Luciana P ^a   Ribeiro, Eliane B ^a   Oller do Nascimento, Claudia M ^a   Oyama, Lila M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

3T3 L1 adipocyte; Adiponectin; Angiotensinogen; Fructose; Glucose; Haptoglobin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSINOGEN; FRUCTOSE; GLUCOSE; HAPTOGLOBIN; HEXOSE; MESSENGER RNA; SUCROSE;

ADIPOCYTE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CELL ASSAY; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN 3T3; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANGIOTENSINOGEN; ANIMALS; CARDIOVASCULAR DISEASES; DIETARY SUCROSE; FRUCTOSE; GENE EXPRESSION; GLUCOSE; HAPTOGLOBINS; INSULIN RESISTANCE; MICE; RISK FACTORS;

EID: 77957687878     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2010.06.012     Document Type: Article

References (50)

1. Johnson R.J., Segal M.S., Sautin Y., Nakagawa T., Feig D.I., Kang D.H., et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007, 86:899-906.
2. Wylie-Rosett J., Segal-Isaacson C.J., Segal-Isaacson A. Carbohydrates and increases in obesity: does the type of carbohydrate make a difference?. Obes Res 2004, 12:124S-129S.
3. Tappy L., Lê K.A., Tran C., Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition 2010.
4. Cheal K.L., Abbasi F., Lamendola C., et al. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004, 53:1195-1200.
5. Stanhope K.L., Havel P.J. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 2008, 88:1733S-1737S.
6. Fried S.K., Rao S.P. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 2003, 78:873S-880S.
7. Bizeau M.E., Pagliassotti M.J. Hepatic adaptations to sucrose and fructose. Metabolism 2005, 54:1189-1201.
8. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006, 580:2917-2921.
9. Trayhurn P., Beattie J.H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001, 60:329-339.
10. Friedrichs W.E., Navarijo-Ashbaugh A.L., Bowman B.H., Yang F. Expression and inflammatory regulation of haptoglobin gene in adipocytes. Biochem Biophys Res Commun 1995, 209:250-256.
11. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002, 103:137-142.
12. Ronti T., Lupattelli G., Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006, 64:355-365.
13. Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148:293-300.
14. Kratchmarova I., Kalume D.E., Blagoev B., Scherer P.E., Podtelejnikov A.V., Molina H., et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002, 1:213-222.
15. Chiellini C., Bertacca A., Novelli S.E., Gorgun C.Z., Ciccarone A., Giordano A., et al. Obesity modulates the expression of haptoglobin in the white adipose tissue via TNF-α. J Cell Physiol 2002, 190:251-258.
16. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006, 74:443-477.
17. Mcmillan D.E. Increased levels of acute-phase serum proteins in diabetes. Metabolism 1989, 38:1042-1046.
18. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 1999, 353:1649-1652.
19. Engström G., Stavenow L., Hedblad B., Lind P., Eriksson K.F., Janzon L., et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 2003, 52:442-447.
20. Chiellini C., Santini F., Marsili A., Berti P., Bertacca A., Pelosini C., et al. Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab 2004, 89:2678-2683.
21. Cid M.C., Grant D.S., Hoffman G.S., Auerbach R., Fauci A.S., Kleinman H.K. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993, 91:977-985.
22. Matsubara M. Genetic determination of human essential hypertension. Tohoku J Exp Med 2000, 192:19-33.
23. Kumar A., Li Y., Patil S., Jain S. A haplotype of the angiotensinogen gene is associated with hypertension in African Americans. Clin Exp Pharmacol Physiol 2005, 32:495-502.
24. Van Harmelen V., Ariapart P., Hoffstedt J., Lundkvist I., Bringman S., Arner P. Increased adipose angiotensinogen gene expression in human obesity. Obes Res 2000, 8:337-341.
25. Gorzelniak K., Engeli S., Janke J., Luft F.C., Sharma A.M. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 2002, 20:965-973.
26. Engeli S., Negrel R., Sharma A.M. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000, 35:1270-1277.
27. Hainault I., Nebout G., Turban S., Ardouin B., Ferré P., Quignard-Boulangé A. Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am J Physiol Endocrinol Metab 2002, 282:E59-E66.
28. Boustany C.M., Bharadwaj K., Daugherty A., Brown D.R., Randall D.C., Cassis L.A. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004, 287:R943-R949.
29. Do Nascimento C.O., Hunter L., Trayhurn P. Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines, catecholamines, and PPARgamma. Biochem Biophys Res Commun 2004, 313:702-708.
30. Ross S.A., Chen X., Hope H.R., Sun S., McMahon E.G., Broschat K., et al. Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: increased glucose flux vs glucosamine treatment. Biochem Biophys Res Commun 2000, 273:1033-1041.
31. Trayhurn P., Duncan J.S., Nestor A., Thomas M.E., Rayner D.V. Chemiluminescent detection of mRNAs on northern blots with digoxigenin end-labeled oligonucleotides. Anal Biochem 1994, 222:224-230.
32. Trayhurn P., Duncan J.S., Nestor A., Thomas M.E., Eastmond N.C., Rayner D.V. Rapid chemiluminescent detection of mRNAs on Northern blots with digoxigenin end-labelled oligonucleotides. Electrophoresis 1995, 16:341-344.
33. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
34. Elliott S.S., Keim N.L., Stern J.S., Teff K., Havel P.J. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002, 76:911-922.
35. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314:1-16.
36. Xi L., Qian Z., Xu G., Zheng S., Sun S., Wen N., et al. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. J Nutr Biochem 2007, 18:64-72.
37. Shepherd P.R., Gibbs E.M., Wesslau C., Gould G.W., Kahn B.B. Human small intestine facilitative fructose/glucose transporter (GLUT5) is also present in insulin-responsive tissues and brain. Investigation of biochemical characteristics and translocation. Diabetes 1992, 41:1360-1365.
38. Hajduch E., Darakhshan F., Hundal H.S. Fructose uptake in rat adipocytes: GLUT5 expression and the effects of streptozotocin-induced diabetes. Diabetologia 1998, 41:821-828.
39. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133.
40. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20:1595-1599.
41. Pellmé F., Smith U., Funahashi T., Matsuzawa Y., Brekke H., Wiklund O., et al. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003, 52:1182-1186.
42. Miller A.W., Hoenig M.E., Ujhelyi M.R. Mechanisms of impaired endothelial function associated with insulin resistance. Cardiovasc Pharmacol Ther 1998, 3:125-134.
43. Park S.K., Oh S.Y., Lee M.Y., Yoon S., Kim K.S., Kim J.W. CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 2004, 53:2757-2766.
44. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R., et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 2002, 99:10730-10735.
45. Lin Y., Berg A.H., Iyengar P., Lam T.K., Giacca A., Combs T.P., et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 2005, 280:4617-4626.
46. Ghanim H., Mohanty P., Pathak R., Chaudhuri A., Sia C.L., Dandona P. Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care 2007, 30:1406-1411.
47. Jones B.H., Standridge M.K., Taylor J.W., Moustaïd N. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol 1997, 273:R236-R242.
48. Gabriely I., Yang X.M., Cases J.A., Ma X.H., Rossetti L., Barzilai N. Hyperglycemia modulates angiotensinogen gene expression. Am J Physiol Regul Integr Comp Physiol 2001, 281:R795-R802.
49. Vasdev S., Longerich L., Gill V. Prevention of fructose-induced hypertension by dietary vitamins. Clin Biochem 2004, 37:1-9.
50. Juan C.C., Au L.C., Fang V.S., Kang S.F., Ko Y.H., Kuo S.F., et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 2001, 289:1328-1333.